Enigma of otologic immunoglobulin G4–related disease, COVID-19, and uncontrolled diabetes: The unholy trinity

Otologic immunoglobulin G4–related disease (IgG4-RD) is a rare and a relatively newer pathology. COVID-19, IgG4-RD, and type 2 diabetes, all have independent capabilities to considerably affect the immune system. The immunological effects of COVID are a global conundrum; consequently, the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Ashish, Patnaik, Uma, Singh, Kamalpreet, Jayadevan, Jijesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721396/
https://www.ncbi.nlm.nih.gov/pubmed/36504510
http://dx.doi.org/10.1016/j.mjafi.2022.10.009
Descripción
Sumario:Otologic immunoglobulin G4–related disease (IgG4-RD) is a rare and a relatively newer pathology. COVID-19, IgG4-RD, and type 2 diabetes, all have independent capabilities to considerably affect the immune system. The immunological effects of COVID are a global conundrum; consequently, the association of this trio (otologic IgG4-RD, COVID-19, and type 2 diabetes), the only reported case in literature, paves the way for a fascinating interplay to explore the knowledge of which would help optimize treatment and improve disease outcomes.

Ejemplares similares